Search - tctmd.com

Displaying 861 - 880 of 904

Sort: Relevancy | Date

News Daily News

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

Todd Neale

December 09, 2015

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Conference News VEITH 2015

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

L.A. McKeown

November 24, 2015

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

News Daily News

Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest

Yael L. Maxwell

November 03, 2015

News Conference News TCT 2015

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

October 11, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

August 13, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Industry News

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

July 28, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

Advertisement

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content